Log in to save to my catalogue

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17d93aa4ba89495e900428b300c74ae5

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

About this item

Full title

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-07, Vol.13 (7), p.621-621, Article 621

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like protein 8 (ANGPTL8) in pathological cardiac hypertrophy. We...

Alternative Titles

Full title

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_17d93aa4ba89495e900428b300c74ae5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17d93aa4ba89495e900428b300c74ae5

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-05029-8

How to access this item